-
BISC 2024 | Professor Xiaomei Tong: Clinical Practice Guidelines for the Use of Meropenem in Treating Neonatal Sepsis (2024 Edition)
Neonatal sepsis refers to the systemic inflammatory response syndrome caused by various pathogens in newborns, ranking as the third leading cause of neonatal mortality globally. Meropenem is one of the most widely used broad-spectrum antibiotics in the treatment of neonatal sepsis. However, its irrational use has led to an increasingly serious problem of bacterial multidrug…
-
2024 National Breast Cancer Congress | Professor Yingying Xu: Reflections on Translational Research Based on Neoadjuvant Platforms
Currently, neoadjuvant therapy has become an optimized treatment modality for locally advanced and some early-stage breast cancers. It can optimize local surgery by downsizing tumors and provide efficacy and prognostic information to guide adjuvant therapy, thus improving survival. Moreover, it serves as an excellent platform for personalized treatment efficacy prediction and new drug development. Translational…
-
BISC 2024 | Professor Wenjie Yang : Rational Use of Oral Antimicrobial Agents in Urinary Tract Infections
Urinary tract infections (UTIs) are commonly encountered in clinical practice, yet their treatment is not as straightforward as many assume. Professor Wenjie Yang from the Department of Infectious Diseases at Tianjin City First Central Hospital begins with epidemiology, etiology, and resistance trends of UTIs, and emphasizes the principles and precautions of treating UTIs with oral…
-
EBMTChina’s Voice| Professor Tong Wu: Innovative Explorations in the Application of Hematopoietic Stem Cell Transplantation Technology
The 50th European Society for Blood and Marrow Transplantation (EBMT) Annual Meeting was held in Glasgow, UK, from April 14th to 17th, 2024. The conference focused on the latest developments in stem cell transplantation and cell therapy, pushing forward better clinical outcomes for patients with hematologic diseases and blood cancers. At this meeting, Dr. Gao’s…
-
Exclusive Interview | Academician Yuming Lu : The Application of Liquid Biopsy Based on Plasma DNA Fragmentomics in Early Cancer Screening
Liquid biopsy is a cutting-edge technology that utilizes molecular biomarkers in human body fluids for analysis, thereby obtaining relevant disease information. In the era of precision medicine, liquid biopsy has become an indispensable tool in the field of tumor diagnosis and treatment. It has received extensive attention and research for its applications in early tumor…
-
BISC 2024 | Professor Yunsong Yu: The Current Epidemic Situation and Challenges of CRO Infections in China
In recent years, the detection rate of carbapenem-resistant Gram-negative bacteria (CRO) in China has remained high, posing serious challenges to clinical treatments and patient outcomes. The limited therapeutic options have left many clinical needs unmet. At the recent Fourth National Conference on Bacterial and Fungal Infections organized by the Chinese Medical Association (BISC 2024), Professor…
-
Professor Rong Fan: Precision Screening for Liver Cancer Patients in China
Primary liver cancer is currently the fourth most common malignant tumor and the second leading cause of cancer death in China, posing a serious threat to the health and well-being of the population. Reducing the burden associated with liver cancer remains a major challenge in the fields of public health and chronic disease prevention in…
-
Professor Chunrong Ju Provides a Comprehensive Overview of IFD Diagnosis and Treatment Strategies in SOT Recipients at BISC 2024
Solid Organ Transplantation (SOT) is a crucial procedure for saving the lives of patients with end-stage organ failure. In recent years, the field of SOT has flourished in China, with significant improvements in the number of transplants and treatment outcomes. However, infections remain a critical factor affecting the survival and quality of life of SOT…
Connecting Medical Expertise through Media